ES2071833T3 - Agente para neutralizar la actividad procoagulante asociada a celulas tumorales. - Google Patents

Agente para neutralizar la actividad procoagulante asociada a celulas tumorales.

Info

Publication number
ES2071833T3
ES2071833T3 ES90916090T ES90916090T ES2071833T3 ES 2071833 T3 ES2071833 T3 ES 2071833T3 ES 90916090 T ES90916090 T ES 90916090T ES 90916090 T ES90916090 T ES 90916090T ES 2071833 T3 ES2071833 T3 ES 2071833T3
Authority
ES
Spain
Prior art keywords
agent
neutralize
tumor cells
activity associated
procoagulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90916090T
Other languages
English (en)
Inventor
Christiaan Reutelingsperger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of ES2071833T3 publication Critical patent/ES2071833T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

EL OBJETO DE ESTA INVENCION ES EL USO DE UNA PROTEINA ANTICOAGULANTE DE LA FAMILIA ANEXINA COMO AGENTE PARA PREVENIR LA METASTASIS DE TUMORES.
ES90916090T 1989-11-11 1990-11-08 Agente para neutralizar la actividad procoagulante asociada a celulas tumorales. Expired - Lifetime ES2071833T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3937607A DE3937607A1 (de) 1989-11-11 1989-11-11 Verwendung eines antikoagulanz zur behandlung von tumorerkrankungen

Publications (1)

Publication Number Publication Date
ES2071833T3 true ES2071833T3 (es) 1995-07-01

Family

ID=6393365

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90916090T Expired - Lifetime ES2071833T3 (es) 1989-11-11 1990-11-08 Agente para neutralizar la actividad procoagulante asociada a celulas tumorales.

Country Status (9)

Country Link
EP (1) EP0500602B1 (es)
JP (1) JPH05501876A (es)
AT (1) ATE120371T1 (es)
CA (1) CA2068312A1 (es)
DE (2) DE3937607A1 (es)
DK (1) DK0500602T3 (es)
ES (1) ES2071833T3 (es)
HU (1) HU208636B (es)
WO (1) WO1991007187A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3664727B2 (ja) * 1994-01-24 2005-06-29 ネオルクス コーポレイション 放射標識したアネキシン
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
WO1995034315A1 (en) * 1994-06-16 1995-12-21 Neorx Corporation Radiolabeled annexin-galactose conjugates
JPH10512852A (ja) * 1994-12-07 1998-12-08 ネオルクス コーポレイション 放射性標識化アネキシン−ガラクトースクラスター複合体
DE69533366T2 (de) * 1994-12-07 2005-08-04 Neorx Corp., Seattle Radioaktivmarkierte annexin-galaktose-cluster konjugate
US6509316B2 (en) 1995-03-07 2003-01-21 George Washington University Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer
US5935860A (en) 1995-03-07 1999-08-10 The George Washington University Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia
US5696092A (en) * 1995-03-07 1997-12-09 George Washington University Methods and compositions for inhibiting metastasis of epithelial cell-derived cancers
US6288039B1 (en) 1995-03-07 2001-09-11 George Washington University Pharmaceutical compositions methods and kits for treatment and diagnosis of breast cancer
EP1520588B1 (en) 1998-07-13 2014-12-24 Board Of Regents, The University Of Texas System Uses of antibodies to aminophospholipids for cancer treatment
US6818213B1 (en) 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
BR9912053A (pt) 1998-07-13 2001-04-03 Univ Texas Processos de tratamento de câncer utilizando conjugados terapêuticos que se ligam a aminofosfolipìdios
US6406693B1 (en) 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
EP1096955B9 (en) 1998-07-13 2006-07-05 Board of Regents, The University of Texas System Uses of antibodies to aminophospholipids for cancer treatment
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
AU2002252035A1 (en) 2001-02-21 2002-09-12 Surromed, Inc. Modified annexin proteins and methods for preventing thrombosis
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem

Also Published As

Publication number Publication date
JPH05501876A (ja) 1993-04-08
HU9201552D0 (en) 1992-08-28
WO1991007187A1 (de) 1991-05-30
HUT61202A (en) 1992-12-28
ATE120371T1 (de) 1995-04-15
CA2068312A1 (en) 1991-05-12
HU208636B (en) 1993-12-28
DE3937607A1 (de) 1991-05-16
DK0500602T3 (da) 1995-07-10
EP0500602A1 (de) 1992-09-02
EP0500602B1 (de) 1995-03-29
DE59008813D1 (de) 1995-05-04

Similar Documents

Publication Publication Date Title
DK0500602T3 (da) Middel til neutralisering af til tumorceller knyttet prokoagulantaktivitet
ES522085A0 (es) Procedimiento para producir t-p-a humano activador de plasminogeno.
DE3677062D1 (de) Quelle geladener teilchen.
ES238038Y (es) Zapata de guía para camarines y similares de ascensores.
IT7919003A0 (it) Procedimento per la fabbricazione di impiantati nonche' impiantati realizzati con detto procedimento.
ES516555A0 (es) Procedimiento para la obtencion de acidos 1-carboxi-(azaalcanoil o azaaralcanoil)-indolin-2-carboxilicos.
ES517408A0 (es) Procedimiento para la preparacion de biocatalizadores de actividad enzimatica.
ES8403623A1 (es) Procedimiento para la determinacion de bilirrubina directa y total en liquidos corporales.
NO862353D0 (no) Human tumornekrosefaktor.
MX26901A (es) Procedimiento para la reduccion directa de material.
IT8119297A0 (it) Procedimento di iniezione e diformazione della miscela, come pure dispositivo per la realizzazione dello stesso.
IT1090445B (it) Procedimento e composizione per la determinazione di idroperossidi
FI850438L (fi) Foerfarande och anordning foer detaktering av biologiskt aktiva aemnen.
SE8500845D0 (sv) Forfarande for framstellning av glyoxylylspermidin och anvendningen derav for framstellning av 15-deoxispergualin-beslektade foreningar
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
ES2051721T3 (es) Productos activos para impedir las metastasis tumorales.
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
IT7926292A0 (it) Preparazione di alfa beta-dialdeidi e di alfa beta-diacidi insaturi o saturi.
DE3481167D1 (de) Sebosuppressive kosmetische mittel, enthaltend alkoxyaryl-alkanole.
IT7805198A0 (it) Procedimento per la fabbricazione di coltelli.
IT7928033A0 (it) Struttura di lampada fotolampo eprocedimento per la sua fabbricazione.
IT8323139A0 (it) Caviglia per l'assemblaggio di parti di mobili.
SU790670A1 (ru) Хлорид 2-фенил-4-(3,4-диметоксифенил)-7,8-бензо-5,6-дигидротиахромилия, обладающий днк-тропным и ингибирующим биосинтез рнк действием
IT7868329A0 (it) Procedimento perfezionato per la fabbricazione di mobili
IT8183615A0 (it) Procedimento per la fabbricazione di cerniere particolarmente per mobili e cerniere ottenute con tale procedimento.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 500602

Country of ref document: ES